[Form 4] Sally Beauty Holdings, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Sally Beauty Holdings (SBH) senior vice president and chief financial officer reported equity award activity involving company stock. On 11/15/2025, the officer acquired 77,496 shares of common stock at an exercise price of $0, reflecting the vesting and conversion of restricted stock units into shares. On the same date, 29,087 shares of common stock were disposed of at $14.18 per share in a transaction coded "F," typically used for shares withheld or sold to cover taxes. After these transactions, the officer directly beneficially owned 138,145 shares of SBH common stock.

The derivative table shows multiple restricted stock unit awards converting into common stock on a one-for-one basis, including tranches of 12,607, 19,630, 13,151, 15,366, 5,451, 4,873, and 6,418 shares tied to vesting schedules through November 2027, with some performance stock units noted as earned and vested.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Platz Marlo Michelle Cormier

(Last) (First) (Middle)

C/O SALLY BEAUTY HOLDINGS, INC.

3001 COLORADO BOULEVARD

(Street)

DENTON TX 76210

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Sally Beauty Holdings, Inc. [ SBH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP & CFO

3. Date of Earliest Transaction (Month/Day/Year)
11/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/15/2025		M		77,496	A	$0	167,232	D
Common Stock	11/15/2025		F		29,087	D	$14.18	138,145	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units(1)	$0	11/15/2025		M			12,607	11/15/2025(2)	11/15/2027	Common Stock	12,607	$0	25,214	D
Restricted Stock Units (1)	$0	11/15/2025		M			19,630	11/15/2025(3)	11/15/2026	Common Stock	19,630	$0	19,632	D
Restricted Stock Units (1)	$0	11/15/2025		M			13,151	11/15/2025(4)	11/15/2025	Common Stock	13,151	$0	0	D
Restricted Stock Units (1)(5)	$0	11/15/2025		M			15,366	11/15/2025	11/15/2025	Common Stock	15,366	$0	0	D
Restricted Stock Units (1), (5)	$0	11/15/2025		M			5,451	11/15/2025	11/15/2025	Common Stock	5,451	$0	0	D
Restricted Stock Units (1), (5)	$0	11/15/2025		M			4,873	11/15/2025	11/15/2025	Common Stock	4,873	$0	0	D
Restricted Stock Units (1), (5)	$0	11/15/2025		M			6,418	11/15/2025	11/15/2025	Common Stock	6,418	$0	0	D

Explanation of Responses:

1. Restricted stock units (RSUs) convert into common stock on a one-for-one basis.

2. These RSUs vested and will vest in equal installments on November 15, 2025, November 15, 2026, and November 15, 2027.

3. These RSUs vested and will vest in equal installments on November 15, 2024, November 15, 2025, and November 15, 2026.

4. These RSUs vested in equal installments on November 15, 2023, November 15, 2024, and November 15, 2025.

5. Reflects earned and vested performance stock units (PSUs).

	/s/ Rebecca L. Morley, Attorney-in-Fact	11/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did SBH's CFO report on this Form 4?

The SBH senior vice president and chief financial officer reported the vesting and conversion of restricted stock units into 77,496 shares of common stock at an exercise price of $0, along with a disposition of 29,087 shares at $14.18 per share on 11/15/2025.

How many SBH shares does the reporting person own after the 11/15/2025 transactions?

Following the reported transactions on 11/15/2025, the reporting officer directly beneficially owned 138,145 shares of Sally Beauty Holdings common stock.

What do the transaction codes M and F mean in the SBH Form 4?

Code M on the Form 4 denotes the exercise or conversion of derivative securities, such as restricted stock units converting into common stock. Code F denotes a disposition of shares, commonly associated with shares withheld or sold to satisfy tax obligations upon vesting.

What restricted stock unit (RSU) awards are reported for SBH's CFO?

The filing reports several RSU awards, each converting one-for-one into common stock, with tranches of 12,607, 19,630, 13,151, 15,366, 5,451, 4,873, and 6,418 shares, tied to vesting schedules that include dates through November 2027.

Are performance stock units (PSUs) included in the SBH Form 4 transactions?

Yes. The explanation of responses notes that some of the reported awards reflect earned and vested performance stock units (PSUs), which convert into common stock on the same one-for-one basis as other restricted stock units.

What is the vesting schedule for some of the SBH RSU awards?

One RSU grant vested and will vest in equal installments on November 15, 2025, November 15, 2026, and November 15, 2027, while another vested and will vest in equal installments on November 15, 2024, November 15, 2025, and November 15, 2026.

Who is the reporting person on this SBH Form 4 and what is their role?

The reporting person is an officer of Sally Beauty Holdings, Inc., serving as SVP & CFO (senior vice president and chief financial officer), filing individually as indicated on the form.